Metraipolis › archive › dc_8fa406ee9643

Targeting G6PD (Glucose-6-Phosphate Dehydrogenase) as a Biomarker of Therapeutic Vulnerability in Renal Cell Carcinoma — Europe PMC PMID:41898704

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898704
DOI
10.3390/ijms27062844
License (as archived)
solo-consultazione
Archived
2026-11-04T04:32:15.353Z
SHA-256 of the archived text
644e3b4f6c0e50c50e87090f6c6fcdd7f44a8fc32b89f0a18fcd469cf7d1252c
Stable URL of this page
https://metraipolis.com/documento/dc_8fa406ee9643

How to cite

Targeting G6PD (Glucose-6-Phosphate Dehydrogenase) as a Biomarker of Therapeutic Vulnerability in Renal Cell Carcinoma — Europe PMC PMID:41898704 — Europe PMC (en), https://europepmc.org/article/MED/41898704 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fa406ee9643 (Metraipolis archive dc_8fa406ee9643, sha256 644e3b4f6c0e50c50e87090f6c6fcdd7f44a8fc32b89f0a18fcd469cf7d1252c)
BibTeX
@misc{dc8fa406ee9643,
  title = {Targeting G6PD (Glucose-6-Phosphate Dehydrogenase) as a Biomarker of Therapeutic Vulnerability in Renal Cell Carcinoma — Europe PMC PMID:41898704},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898704},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fa406ee9643; sha256 644e3b4f6c0e50c50e87090f6c6fcdd7f44a8fc32b89f0a18fcd469cf7d1252c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898704. Agents can read the archived copy with the MCP tool read_document.